Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

MCI patients with COVID-19 Have Increased Progression to Dementia at 18 months

Author:Kirkpatrick, Angelia   Delpirou Nouh, Claire   Husain, Farhat   Xu, Chao   Vincent, Andrea   Yabluchanskiy, Andriy   Csiszar, Anna   Ungvari, Zoltan   Scott, Jim   Prodan, Calin   

Session Name:S39: Neurobiology of Dementia  

Topic:Aging and Dementia  

Program Number:S39.010  

Author Institution:University of Oklahoma Health Sciences Center, Oklahoma City, OK  Department of Veterans Affairs, Oklahoma City, OK  University of Oklahoma, Norman, Norman, OK  

A Rare Mutation Associated with Cerebral Arteriopathy with Subcortical Infarct and Leukoencephalopathy (CADASIL)

Author:Delpirou Nouh, Claire   Mahmoud, Noor   Chainakul, Juliane   Hamilton, Robert   Sidorov, Evgeny   

Session Name:P2: Cerebrovascular Disease and Interventional Neurology: Interesting Cases 1  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P2.002  

Author Institution:University of Oklahoma Health Science Center, Department of Neurology, Oklahoma City, OK  

Severe Hypoglycemic Brain Injury Associated with Diffuse Restricted Diffusion on MRI Brain Sparing Cerebellar Lobes

Author:Ribeiro, Estevao   Gatchoff, Philion   Delpirou Nouh, Claire   Moon, Joon-Shik   

Session Name:P10: Neurocritical Care: Neuroimaging  

Topic:Neurocritical Care  

Program Number:P10.006  

Author Institution:University of Oklahoma Health Sciences Center Department of Neurology, Oklahoma City, OK  University of Oklahoma Health Sciences Center Department of Neurology, OKC, OK  University of Oklahoma Health Sciences Center Department of Neurology, Edmond, OK  

Effects of Ozanimod on Cognitive Processing Speed: Findings From the Phase 3 SUNBEAM and DAYBREAK Extension Trials

Author:DeLuca, John   Cohen, Jeffrey A.   Cree, Bruce A. C.   Cheng, Chun-Yen   Sheffield, James K.   Riolo, Jon V.   Silva, Diego   Comi, Giancarlo   Kappos, Ludwig   

Session Name:P6: MS Clinical Trials  

Topic:MS and Inflammatory Disease  

Program Number:P6.001  

Author Institution:Kessler Foundation, West Orange, New Jersey, and Departments of Physical Medicine and Rehabilitation, and Neurology, Rutgers - New Jersey Medical School, Newark, New Jersey, West Orange, NJ  Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, Cleveland, OH  Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, San Francisco, CA  Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ  Vita-Salute San Raffaele University, and Casa di Cura del Policlinico, Milan, Italy, Milan, Italy  Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland  

Thrombolytic Therapy for Non-arteritic Central Retinal Artery Occlusion in an Academic Multi-site Stroke Center

Author:Alhayek, Nour   Sobczak, Jacob   Weinberg, Emilie   Demaerschalk, Bart   Dumitrascu, Oana M   

Session Name:S45: Cerebrovascular Disease and Interventional Neurology: Meta-analyses and Outcomes Research  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:S45.010  

Author Institution:Mayo Clinic Arizona, Scottsdale, AZ